Allakos Inc. appointed Craig Paterson as Chief Medical Officer. Dr. Paterson has served as the Company’s Senior Vice President of Clinical Development and Medical Affairs since joining in March 2021. Dr. Paterson joined Allakos as SVP of clinical development and medical affairs in March 2021, reporting to Dr. Rasmussen. Prior to Allakos, he was the Lead Program Physician for Immunodermatology at UCB, CMO at Vivelex Pharmaceuticals, and was Senior Vice President of Medical and Clincal Development at Salix Pharmaceuticals where he was responsible for the development of Xifaxin550, Relistor and other gastrointestinal drugs.